HROWHarrow, Inc. Common Stock

CSNasdaq (XNAS)·USD

Identity

Security key: 16626
Ticker: HROW
Type: CS — Common Stock
Exchange: Nasdaq(XNAS)
Venue group: NASDAQ
Operating MIC: XNAS
Market: stocks
Locale: us
Currency: USD
Listed: 2007-04-30
Round lot: 100
Active: Yes
Last seen in a load: 2026-08-14 20:49
Vendor updated: 2026-08-13 06:09
Ticker root / suffix: HROW

Detail

Enriched 2026-08-14 20:47

Market cap: $1,475,521,776
Shares outstanding (class): 37,275,107
Shares outstanding (weighted): 37,487,850
SIC: 2834 PHARMACEUTICAL PREPARATIONS
Employees: 373
Location: NASHVILLE, TN
Homepage: https://www.harrow.com
Description: Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company partners with U.S. eyecare professionals to develop products used to manage ophthalmic conditions affecting both the front and back of the eye, such as dry eye disease, cataracts, refractive errors, glaucoma, etc. Its portfolio of branded ophthalmic pharmaceuticals includes Iheezo, Vevye, Byooviz Opuviz, Natacyn, Maxitrol, Maxidex, etc. Additionally, the company's development pipeline comprises candidates like MELT-300, H-N08, CR-01, and MELT-210, being developed to address unmet needs in eye care and selected adjacent markets. Its reportable segments are: Branded, which derives maximum revenue, and ImprimisRx.

Market cap and share counts drift.

Funds holding this security

76 funds · 76 positions · $118.56M reported value, as of 2026-03-31

All holders →

Fund	Ticker	Position value	% of fund	Balance	Match
VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS	VTI	$35.31M	0.00%	1,001,445 NS	FIGI
iShares Russell 2000 ETF iShares Trust	IWM	$27.17M	0.04%	770,439 NS	FIGI
VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS	VXF	$12.98M	0.02%	368,005 NS	FIGI
iShares Russell 2000 Growth ETF iShares Trust	IWO	$9.05M	0.07%	256,748 NS	FIGI
State Street(R) SPDR(R) S&P(R) Pharmaceuticals … SPDR SERIES TRUST	XPH	$5.64M	1.83%	159,813 NS	FIGI
iShares U.S. Pharmaceuticals ETF iShares Trust	IHE	$3.25M	0.32%	92,131 NS	FIGI
iShares Micro-Cap ETF iShares Trust	IWC	$2.80M	0.23%	79,522 NS	FIGI
Clearwater Select Equity Fund Clearwater Investment Trust	—	$2.79M	0.64%	79,181 NS	FIGI
Master Small Cap Index Series Quantitative Master Series LLC	—	$1.86M	0.04%	52,830 NS	FIGI
Principal U.S. Small-Cap ETF Principal Exchange-Traded Funds	PSC	$1.75M	0.10%	49,511 NS	FIGI
iShares Core S&P Total U.S. Stock Market ETF iShares Trust	ITOT	$1.55M	0.00%	43,969 NS	FIGI
Royce Smaller-Companies Growth Fund ROYCE FUND	—	$1.40M	0.78%	39,700 NS	FIGI
EQ/2000 Managed Volatility Portfolio EQ Advisors Trust	—	$1.19M	0.03%	33,622 NS	FIGI
Buffalo Early Stage Growth Fund Buffalo Funds	—	$954.9K	1.56%	27,083 NS	FIGI
Fidelity Small Cap Growth Index Fund Fidelity Salem Street Trust	—	$845.9K	0.07%	23,991 NS	FIGI

How positions resolve to the securities master. FIGI_COMPOSITE is exact identifier equality — both sides got the FIGI from Bloomberg. TICKER is a narrow fallback used only where the master row carries no FIGI at all (2,389 rows do not, disproportionately Irish-domiciled US listings like LIN and ACN). Roughly 22% of all positions resolve to the master.

Funds holding this security

Identifiers

master.security_identifier

TICKERHROW
FIGI_COMPOSITEBBG000QXWY44
FIGI_SHARE_CLASSBBG001SSTRN9
CIK0001360214
ISINUS4158581094
Resolved through OpenFIGI from a holdings ISIN, not supplied by the securities vendor.

Identifiers

Classification

classification.v_security_classification

Asset class: Equity
Sector: Health Care
Industry: Pharmaceuticals
Source: LLMunreviewed
Self-reported confidence: 0.95
Model: deepseek
Rationale: Common stock of a pharmaceutical company, classified under healthcare and pharmaceuticals based on SIC code.

Classifications are unreviewed model output. All 5,771 assignments carry source = LLM and is_reviewed = false. Confidence is the model’s own estimate and is not calibrated — it clustered at 0.90–0.98 across the whole first pass, including rows that later proved wrong. Use it to order a review queue, not as a probability. Two share classes of one issuer can disagree.

Classification

Fund data

Not linked to a fund series.

Either this is not a fund, or it is one the SEC share-class snapshot cannot reach — commodity trusts and notes have no series ID at all.